View Older Stories View More Recent Stories
-
Market Vectors Semiconductor ETF (SMH) call put ratio 1 call to 1.5 puts into SEMICON West conference
-
Meta Platforms (META) call put ratio 1.9 calls to 1 put amid rally
-
CareDx, Inc (CDNA) PT Raised to $74 at BTIG
-
Jefferies: India regulator proposes insurance commission cuts
-
Golar LNG Ltd. (GLNG) PT Raised to $75 at BTIG
-
McDonald's (MCD) PT Lowered to $270 at TD Cowen
-
TD Cowen Reiterates Buy Rating on Alamar Biosciences (ALMR)
-
Okta, Inc (OKTA) PT Raised to $215 at Stifel
-
Stocks expected to have increasing option volume: MGM P VKTX COST SFIX DRI
-
Oppenheimer Reiterates Outperform Rating on Harmony Biosciences Holdings Inc. (HRMY)
-
Cintas (CTAS) PT Raised to $230 at Truist Securities
-
Paychex (PAYX) PT Lowered to $113 at BMO Capital
-
Oppenheimer Reiterates Outperform Rating on Ionis Pharmaceuticals (IONS)
-
Arcturus Therapeutics (ARCT) PT Lowered to $20 at BTIG
-
Wolfe Research Starts Brinks Co. (BCO) at Outperform
-
Goldman Sachs Assumes Tarsus Pharmaceuticals (TARS) at Buy
-
Goldman Sachs Starts Revolution (RVMD) at Buy
-
Goldman Sachs Assumes Madrigal Pharmaceuticals (MDGL) at Buy
-
Goldman Sachs Resumes Kymera Therapeutics (KYMR) at Early-Stage Biotech
-
Goldman Sachs Assumes Krystal Biotech (KRYS) at Buy
-
Goldman Sachs Assumes Kodiak Sciences Inc. (KOD) at Neutral
-
Goldman Sachs Assumes Jazz Pharmaceuticals (JAZZ) at Buy
-
Goldman Sachs Assumes Insmed (INSM) at Buy
-
Goldman Sachs Assumes Contineum Therapeutics (CTNM) at Early-Stage Biotech
-
Goldman Sachs Assumes Arrowhead Pharma (ARWR) at Neutral
-
Goldman Sachs Resumes Alkermes (ALKS) at Neutral
-
Goldman Sachs Resumes AbCellera Biologics (ABCL) at Neutral
-
Spark Expands Arapaima's Gallium-Rare Earth Portfolio with Boa Vista Surface Results
-
Okta, Inc (OKTA) PT Raised to $240 at Jefferies
-
Goldman Sachs Assumes Iovanace Biotherapeutics (IOVA) at Buy
-
Goldman Sachs Assumes Sagimet Biosciences Inc (SGMT) at Sell
-
Solaris Energy Infrastructure (SEI) PT Raised to $101 at Stifel
-
Okta, Inc (OKTA) PT Raised to $200 at TD Cowen
-
Goldman Sachs Reiterates Sell Rating on Intuit (INTU)
-
Okta, Inc (OKTA) PT Raised to $200 at Mizuho
-
Stifel Reiterates Buy Rating on Eupraxia Pharmaceuticals (EPRX)
-
Emkay Global Upgrades Gail (India) Ltd. (GAIL:IN) (GAILF) to Buy (1)
-
Shift4 Payments (FOUR) PT Lowered to $46 at Mizuho
-
Vail Resorts (MTN) PT Lowered to $160 at Mizuho
-
Citi lowers McDonald's price target to $305, keeps Buy rating
-
Everpure (P) PT Raised to $160 at Citi
-
Citi Adds Royal Caribbean Cruises to 90-Day Positive Catalyst Watch List
-
McDonald's (MCD) PT Lowered to $310 at BMO Capital
-
Solaris Energy Infrastructure (SEI) PT Raised to $100 at Citi
-
Pepsico (PEP) PT Lowered to $142 at Citi
-
William Blair Reiterates Outperform Rating on Meta Platforms Inc. (META)
-
Truist Securities Starts MiniMed Group (MMED) at Buy
-
McDonald's (MCD) PT Lowered to $300 at Evercore ISI
-
Silver Range Defines Targets at the Drum Property in Utah
-
Spartan Metals Receives BLM Approval for Seven Additional Drill Sites at its Tungstonia Claims, Nevada
